Avid Bioservices, Inc.

CDMO · NASDAQ
Analyze with AI
10/31/2024
7/31/2024
4/30/2024
1/31/2024
Operating Activities
Net Income-$25,188-$5,534-$123,104-$6,006
Dep. & Amort.$5,772$2,824$2,859$2,927
Deferred Tax$0$0$117,916-$1,084
Stock-Based Comp.$3,469$2,665$2,463$2,459
Change in WC$833-$3,940-$1,511$5,225
Other Non-Cash$10,236$305$902$12,177
Operating Cash Flow-$4,878-$3,680$1,257$3,687
Investing Activities
PP&E Inv.$15,263-$1,311-$5,693-$4,488
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$18,710$0$0$0
Investing Cash Flow-$3,447-$1,311-$5,693-$4,488
Financing Activities
Debt Repay.-$622-$350$10,474-$299
Stock Issued$0$616$14$384
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$109$616$1,360$384
Financing Cash Flow-$513$266$11,834$85
Forex Effect$0$0$0$0
Net Chg. in Cash$34-$4,725$7,398-$716
Supplemental Information
Beg. Cash$150,307$38,106$30,708$31,424
End Cash$33,415$33,381$38,106$30,708
Free Cash Flow$10,385-$4,991-$4,436-$801
Avid Bioservices, Inc. (CDMO) Financial Statements & Key Stats | AlphaPilot